Table 1 Group differences in demographic and clinical variables of the final sample (n = 110) and enrolled participants who were excluded (n = 93) at admission (t0)
| Â | final sample | enrolled but excluded | Â | ||
|---|---|---|---|---|---|
Variable | n | Â | n | Â | Test |
Gender | 110 | 63 f / 47 m | 92 | 47 f / 45 m | p = .398 |
Comorbidity of mental disorder | 110 | 88 | 93 | 61 | p = .026 |
Psychotropic medication | 110 | 62 none / 48 at least one | 93 | 54 none / 39 at least one | p = .887 |
| Â | Â | M (SD) | Â | M (SD) | Â |
Age (years) | 110 | 33.8 (10.8) | 92 | 32.7 (10.0) | t(197.83) = 0.74, p = .463 |
Socioeconomic status | 110 | 9.7 (3.8) | 87 | 9.9 (3.7) | t(186.49) = −0.30, p = .761 |
Y-BOCS | 110 | 23.4 (4.4) | 91 | 23.3 (5.2) | t(177.85) = 0.17, p = .862 |
OCI-R | 110 | 29.9 (13.2) | 91 | 28.7 (11.8) | t(197.9) = 0.70, p = .484 |
MADRS | 110 | 13.1 (7.0) | 91 | 13.7 (9.0) | t(167.93) = −0.49, p = .624 |
BDI-II | 110 | 19.5 (9.9) | 91 | 18.6 (10.2) | t(189.54) = 0.60, p = .547 |
BSI-GSI | 110 | 1.04 (0.54) | 91 | 0.97 (0.59) | t(185.39) = 0.93, p = .356 |
GAF | 110 | 56.0 (8.4) | 89 | 54.5 (8.4) | t(188.73) = 1.25, p = .213 |